SKN CBBA -
SKN CBBA
Cross Border Banking Advisors
SKN | BBVA Strengthens Its Regulatory Capital With €1 Billion Perpetual AT1 Securities Offering

Finance

SKN | BBVA Strengthens Its Regulatory Capital With €1 Billion Perpetual AT1 Securities Offering

By Or Sushan

•

November 19, 2026

Key Takeaways:

  • BBVA has completed a €1 billion issuance of perpetual contingent convertible securities designed to qualify as Additional Tier 1 (AT1) regulatory capital.
  • The securities carry a discretionary annual distribution rate of 6.50% until May 2034, after which the rate resets at a margin of 333.4 basis points above the five-year Mid-Swap Rate.
  • The transaction strengthens BBVA’s regulatory capital resources while providing institutional investors with exposure to a subordinated instrument carrying materially different risks from conventional bank bonds.
  • The offering is not directed at retail investors. Its perpetual structure, conditional distributions and potential conversion into ordinary shares are central to assessing its risk profile.

Banco Bilbao Vizcaya Argentaria (BBVA) has completed a €1 billion capital markets transaction through the issuance of perpetual contingent convertible securities, reinforcing the bank’s regulatory capital structure. The transaction, announced on November 10 and scheduled to close on November 18, 2026, is designed to qualify as Additional Tier 1 (AT1) capital for both BBVA and its consolidated group under applicable solvency regulations.

The issuance represents a deliberate capital-management decision by the Spanish banking group. Rather than raising conventional senior debt, BBVA has used a subordinated instrument that can absorb losses under specified regulatory conditions. This provides the bank with an additional layer of capital resilience while diversifying its funding and capital instruments.

BBVA Uses Perpetual Securities to Reinforce Regulatory Capital

The €1 billion securities are contingently convertible into newly issued BBVA ordinary shares. They are perpetual, meaning they have no contractual final maturity, and are structured with an initial non-call period of seven and a half years. The bank’s official issuance records classify the instrument as PerpNC7.5.

For BBVA, the transaction supports its regulatory capital position without requiring an immediate conventional equity offering. The securities also exclude existing shareholders’ pre-emptive subscription rights. Once fully paid, they are expected to qualify as AT1 capital, an important component of a bank’s loss-absorbing capital framework.

The structure is not equivalent to ordinary borrowing. AT1 instruments rank below senior obligations and can expose investors to losses through conversion or other regulatory intervention. Their purpose is to provide additional protection within the banking system when capital conditions deteriorate.

The 6.50% Distribution Reflects the Instrument’s Risk Structure

BBVA has set an initial annual distribution rate of 6.50%, applicable from November 18, 2026, until May 18, 2034. Following that period, the rate will reset using the five-year Mid-Swap Rate plus a margin of 333.4 basis points.

However, the distribution is discretionary and subject to specified conditions. Investors should not interpret the stated rate as a guaranteed coupon or contractual promise of uninterrupted income. Payments may be cancelled under the instrument’s terms and applicable regulatory requirements. This distinction separates AT1 securities from conventional fixed-income instruments with unconditional contractual interest obligations.

BBVA intends to seek admission of the securities to the Global Exchange Market of Euronext Dublin. The offering is expressly not directed toward retail investors, reflecting its institutional and specialist-investor structure.

Why the Transaction Matters for BBVA and Institutional Investors

For BBVA, the issuance demonstrates continued access to the institutional market for regulatory capital instruments. It also gives the bank flexibility in managing its capital composition while maintaining a framework designed to absorb losses under stress.

For investors, the 6.50% initial distribution must be evaluated alongside subordination, perpetual duration, discretionary payments and contingent conversion risk. The bank’s recent share-price performance alone cannot establish whether the securities are fairly valued; that assessment requires consideration of the issue price, comparable AT1 spreads, BBVA’s capital position and the instrument’s contractual protections.

Looking ahead, the effectiveness of this transaction will depend on how BBVA manages its capital ratios, funding costs and regulatory requirements. For sophisticated investors, the key distinction is between the income offered and the risks assumed to receive it. For a confidential discussion regarding European bank capital instruments and cross-border fixed-income exposure, contact our senior advisory team.

Leave a Reply

Your email address will not be published. Required fields are marked *

More like this